Axsome Therapeutics, Inc.

NY · United States · Reporting entity ID 100001111886

Total reported 2019–2025

$67.5M

#135 of 2,960 reporting companies — 0.1% of all reported industry payments

$42.8M in general payments across 316,908 records, plus $24.7M in research funding across 1,030 records.

How it breaks down

General payments $42,779,386

Research funding $24,700,487

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.